The market is witnessing the emergence of more effective GLP-1s, with several new ones slated for release in 2026-2027, leading to an inevitable escalation of costs
Psychiatry Research 345 , 116380 (2025).
Calorie deficit size matters Too aggressive (1000+ calorie deficit): Lose muscle along with fat Severe fatigue Metabolic slowdown Unsustainable Gallbladder risk Too conservative (200-300 deficit): Very slow progress Easy to wipe out with weekend overeating May not be worth peptide cost Sweet spot (500-750 deficit): 1-1.5 pounds loss per week Muscle preservation Sustainable energy Manageable hunger (especially with GLP-1s) Meal timing and frequency With GLP-1 agonists: Eat when hungry (may be 1-2 meals per day) Don't force food if not hungry Focus on protein when you do eat Small, frequent meals if that feels better With fat burners (AOD 9604): Take fasted in morning Wait 30 minutes before eating Normal meal frequency thereafter General: No magic meal timing for fat loss Total daily intake matters most Find schedule that works for you Supplements worth considering Essential: Protein powder (convenience) Multivitamin (nutritional insurance) Helpful: Omega-3s (health, inflammation) Vitamin D (most people deficient) Magnesium (bowel regularity, sleep) Electrolytes (if low carb or sweating a lot) Optional but potentially beneficial: Creatine (muscle preservation, strength) Fiber supplement (if constipated) Probiotics (gut health) Transitioning off weight loss peptides You can't use GLP-1s forever
The Incretin Effect (Pancreatic Response) GLP-1 travels to the pancreas, where it binds to specific receptors on beta cells
A majority of studies looking at association between AMD and GLP-1 agonist use was conducted on patients with type 2 diabetes
"At Amgen, we believe that deep insights from observational research are critical to advancing patient care
